Company Search:
Advanced Search
Sponsored Links
Oncolytics Biotech Incorporated Company Snapshot
Oncolytics Biotech Incorporated operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oncolytics Biotech Incorporated with three other pharmaceutical manufacturers in North America: Diadexus Incorporated of the United States (2000 sales of $275,000.00 of which 100% was Research contract revenue), BELLUS Health Inc (176,000.00 Canadian Dollars [US$132,033.44 ] of which 100% was Research & Development of Therapeutics), and Mannkind Corporation which is based in the United States ($154,000.00 of which 100% was Therapeutic Products).

Sales Analysis.
  Stock Performance Chart for Oncolytics Biotech Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): .60
(Figures in Canadian Dollars)
1 Week 1.7%   13 Weeks 62.2%  
4 Weeks 110.5%   52 Weeks 39.5%  
Oncolytics Biotech Incorporated Key Data:
  Ticker: ONC Country: Canada
  Exchanges: NAS TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2000 Sales 310,000
(Year Ending Jan 2001).
Employees: 21
  Currency: Canadian Dollars Market Cap: 72,754,933
  Fiscal Yr Ends: December Shares Outstanding: 121,258,222
  Share Type: Common Closely Held Shares: 1,123,250
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.